Last reviewed · How we verify
NCT07367022: PrSM
Portable Sleep Monitors in Children With Autism Spectrum Disorder
trial testing Portable sleep monitor (Nox T3s) in Autism Spectrum Disorder (ASD) in 20 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Lena Xiao |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 12 August 2025 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Portable sleep monitor (Nox T3s)
Conditions studied
- Autism Spectrum Disorder (ASD) — all drugs for Autism Spectrum Disorder (ASD) →
- Obstructive Sleep Apnea (OSA) — all drugs for Obstructive Sleep Apnea (OSA) →
Sponsor
Lena Xiao
Who can join
Adults 6 to 18, any sex, with Autism Spectrum Disorder (ASD) or Obstructive Sleep Apnea (OSA). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to evaluate the ability of a portable sleep monitor to detect obstructive sleep apnea in children with autism spectrum disorder (ASD). The main study objectives are to: 1. Evaluate the correlation between the obstructive apnea-hypopnea index (OAHI) on a portable sleep monitor and an in-laboratory polysomnogram (PSG); 2. Determine the sensitivity and specificity of a portable sleep monitor to diagnose obstructive sleep apnea (OSA); 3. Evaluate patient and family preferences for sleep testing.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07367022
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Autism Spectrum Disorder (ASD)
Currently open trials in the same condition.
- NCT07421830 — An Empowering Parent Training Intervention to Increase Physical Activity in Preschool Aged Children With Autism · NA · recruiting
- NCT07495761 — Prospective Study to Determine the Prevalence of Signs of Central Sensitization in Adults With ASD Without Intellectual · recruiting
- NCT07276750 — Coaching and Leadership in Autism Support Settings · NA · recruiting
- NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study · Phase 1, PHASE2 · recruiting
- NCT07189442 — L-theanine and Paraxanthine for Cognitive Improvement in Adults With ADHD and ASD · NA · recruiting
Other Lena Xiao trials
Trials by the same sponsor.
- NCT07176767 — The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07367022 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lena Xiao
- Last refreshed: 26 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07367022.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing